These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 7575520)
1. Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells. Zhu W; Murtha PE; Young CY Biochem Biophys Res Commun; 1995 Sep; 214(3):1130-7. PubMed ID: 7575520 [TBL] [Abstract][Full Text] [Related]
2. Calpain inhibitors and serine protease inhibitors can produce apoptosis in HL-60 cells. Lu Q; Mellgren RL Arch Biochem Biophys; 1996 Oct; 334(1):175-81. PubMed ID: 8837753 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines. Guan N; Korukonda R; Hurh E; Schmittgen TD; Donkor IO; Dalton JT Int J Oncol; 2006 Sep; 29(3):655-63. PubMed ID: 16865282 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth of human TE2 and C-33A cells by the cell-permeant calpain inhibitor benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone. Mellgren RL; Shaw E; Mericle MT Exp Cell Res; 1994 Nov; 215(1):164-71. PubMed ID: 7957664 [TBL] [Abstract][Full Text] [Related]
5. Calpain-2 as a target for limiting prostate cancer invasion. Mamoune A; Luo JH; Lauffenburger DA; Wells A Cancer Res; 2003 Aug; 63(15):4632-40. PubMed ID: 12907643 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of the growth of WI-38 fibroblasts by benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone: evidence that cleavage of p53 by a calpain-like protease is necessary for G1 to S-phase transition. Zhang W; Lu Q; Xie ZJ; Mellgren RL Oncogene; 1997 Jan; 14(3):255-63. PubMed ID: 9018111 [TBL] [Abstract][Full Text] [Related]
7. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Engedal N; Korkmaz CG; Saatcioglu F Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819 [TBL] [Abstract][Full Text] [Related]
8. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Han S; Inoue H; Flowers LC; Sidell N Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539 [TBL] [Abstract][Full Text] [Related]
10. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Ozoren N; Kim K; Burns TF; Dicker DT; Moscioni AD; El-Deiry WS Cancer Res; 2000 Nov; 60(22):6259-65. PubMed ID: 11103780 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of calpain and caspase-3 prevented apoptosis and preserved electrophysiological properties of voltage-gated and ligand-gated ion channels in rat primary cortical neurons exposed to glutamate. Ray SK; Karmakar S; Nowak MW; Banik NL Neuroscience; 2006 May; 139(2):577-95. PubMed ID: 16504408 [TBL] [Abstract][Full Text] [Related]
12. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide. Eymin B; Dubrez L; Allouche M; Solary E Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846 [TBL] [Abstract][Full Text] [Related]
13. Attenuation of TGF-beta-induced apoptosis in primary cultures of hepatocytes by calpain inhibitors. Gressner AM; Lahme B; Roth S Biochem Biophys Res Commun; 1997 Feb; 231(2):457-62. PubMed ID: 9070300 [TBL] [Abstract][Full Text] [Related]
14. Calpain and caspase-3 inhibitors reduce infarct size and post-ischemic apoptosis in rat heart without modifying contractile recovery. Perrin C; Ecarnot-Laubriet A; Vergely C; Rochette L Cell Mol Biol (Noisy-le-grand); 2003; 49 Online Pub():OL497-505. PubMed ID: 14995081 [TBL] [Abstract][Full Text] [Related]
15. Induction of AP-1 activity by androgen activation of the androgen receptor in LNCaP human prostate carcinoma cells. Church DR; Lee E; Thompson TA; Basu HS; Ripple MO; Ariazi EA; Wilding G Prostate; 2005 May; 63(2):155-68. PubMed ID: 15486991 [TBL] [Abstract][Full Text] [Related]
16. Phorbol ester-induced apoptosis is accompanied by NGFI-A and c-fos activation in androgen-sensitive prostate cancer cells. Day ML; Zhao X; Wu S; Swanson PE; Humphrey PA Cell Growth Differ; 1994 Jul; 5(7):735-41. PubMed ID: 7947388 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969 [TBL] [Abstract][Full Text] [Related]
20. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]